Prosecution Insights
Last updated: April 19, 2026

Examiner: VARGAS, ANNA ELIZABETH

Tech Center 3700 • Art Units: 3783

This examiner grants 59% of resolved cases

Performance Statistics

59.1%
Allow Rate
-10.9% vs TC avg
159
Total Applications
+53.7%
Interview Lift
1238
Avg Prosecution Days
Based on 127 resolved cases, 2023–2026

Rejection Statute Breakdown

0.3%
§101 Eligibility
16.8%
§102 Novelty
51.6%
§103 Obviousness
28.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18637870 Abdominal Tissue Lifting Device Non-Final OA Stetrix, Inc.
18633001 SHEATHS INCLUDING INBUILT MALE LUER CONNECTORS Non-Final OA Boston Scientific Scimed, Inc.
17527132 AUTOMATIC PRESSURE CONTROL DEVICE, SYSTEM, AND METHOD Non-Final OA Drägerwerk AG & Co. KGaA
18127042 Medical Infusion Pump for Delivery of a Fluid Final Rejection Becton, Dickinson and Company
18681018 DUAL MODE AND HYBRID PUMP AND CONTAINER SYSTEMS Non-Final OA ICU Medical, Inc.
16022487 INJECTION APPARATUS Final Rejection Daicel Corporation
16022471 ADMINISTRATION APPARATUS Final Rejection DAICEL CORPORATION
18620385 ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE Non-Final OA Sanofi
16256996 IRRIGATION DAY CASSETTE Final Rejection Johnson & Johnson Surgical Vision, Inc.
17756379 RETAINING DEVICE FOR A URINARY CATHETER AND ASSEMBLY COMPRISING A RETAINING DEVICE WITH A CATHETER Final Rejection RETHINK MEDICAL SL
17670048 Applicator for Intradermal Microneedle Array Patches Final Rejection Tokitae, LLC
17059994 LOW-PROFILE MULTI-AGENT INJECTION SYSTEM AND METHODS Final Rejection PRESAGE BIOSCIENCES, INC.
16889379 DEVICES AND METHODS FOR LOW PRESSURE TUMOR EMBOLIZATION Final Rejection Embolx, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month